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Studies have recently demonstrated that tubal ligation results in a
significant reduction in the subsequent risk of ovarian cancer
(Hankinson et al, 1993; Rosenblatt et al, 1996; Green et al, 1997a;
Kreiger et al, 1997; Miracle-McMahill et al, 1997). Selective
screening for ovarian abnormalities during the procedure cannot
account for the striking deficits in risk (40–60%) that have been
observed. Alternative explanations include possible effects of
reducing ovarian blood supply, destroying tissue at risk, or
reducing exposure of the ovaries to exogenous or endogenous
factors that may be involved in ovarian cancer development.
It has recently been hypothesized that breast cancer risk may
also be reduced by tubal ligation. It is well known that ovarian
ablation substantially reduces breast cancer risk, presumably
because of striking decreases in endogenous hormones (La
Vecchia, 1999). Two recent reports have shown reductions in
breast cancer following tubal ligations (Calle et al, 1999; Kreiger
et al, 1999). Surprisingly, few other epidemiologic investigations
have assessed the relationship of tubal ligations to breast cancer
risk, with one supporting the hypothesis of reduced risk (Shin et al,
1996) and the other showing no such protective effect (Irwin et al,
1988).
A large investigation of breast cancer among younger women,
many of whom reported such procedures, enabled an evaluation of
tubal procedures in relation to risk independent of other risk
factors.
MATERIALS AND METHODS
This population-based case–control study was conducted in three
different geographic areas – the metropolitan areas of Atlanta,
Georgia and Seattle/Puget Sound, Washington, and five counties
of central New Jersey. In Seattle and New Jersey, the study was
confined to women 20–44 years of age, while in Atlanta the age
range was extended through age 54. All women of these ages
newly diagnosed with in situ or invasive breast cancer during the
period 1 May 1990 to 31 December 1992 were identified through
rapid ascertainment systems. All areas were covered by popula-
tion-based cancer registries, and periodic checks against these
registries determined the completeness of case ascertainment.
Hospital records of eligible patients were examined for details on
the clinical and pathologic characteristics of the diagnosed breast
cancers.
Controls in the three geographic areas were ascertained through
a series of 13 waves of random digit dialing (Waksberg, 1978). To
select a sample of women whose ages approximated to the antici-
pated age distribution of cases, information was sought on female
residents who were 20–44 years of age (20–54 years in Atlanta). A
90.5% response rate to the telephone screener was obtained 
from the 16 254 telephone numbers assessed as residential; non-
response consisted of a 5.4% refusal to the telephone screener,
0.8% language problems and 3.3% contact problems.
Structured in-person interviews (median 67 min) covered
demographic factors; reproductive and menstrual history; contra-
ceptive behaviour; use of exogenous hormones; medical and
screening history; anthropometry and physical activity; adolescent
diet; alcohol consumption; smoking; occupations; family history
of cancer; and certain lifestyle factors and opinions about cancer
causation. Subjects were also asked to complete a 100-item dietary
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questionnaire and to consent to a variety of anthropometric
measurements.
Subjects were asked to complete a month-by-month calendar
documenting all contraceptive methods used since menarche.
Pregnancies and other life events were first marked on the
calendar to serve as a frame of reference for changes in contracep-
tive behaviour over time. Information recorded on the calendar
regarding the occurrence of a tubal ligation was used to compute
the age at, interval since, and calendar time of the procedure.
Completed interviews were obtained from 2202 of the 2558
eligible cases (86.1%) and 2009 of the 2477 eligible controls
(81.1%). Reasons for non-interview included subject refusals
(6.4% in cases vs 14.0% in controls), death (0.4% vs 0.2%), illness
(0.6% vs 0.2%), language problems (0.3% vs 1.4%), a move
outside of the study area (0.6% vs 2.3%) and other miscellaneous
reasons (0.2% vs 0.8%). In addition, physician consent for inter-
view was denied for 5.4% of the cases. Among controls, an overall
response rate of 73.4% was achieved through multiplication of the
telephone screener and interview response rates. To assure compa-
rability between the cases and controls, the 29 cases who indicated
on interview that they did not have a residential telephone and the
19 controls with a history of breast cancer were eliminated,
leaving 2173 cases and 1990 controls available for analysis.
Since the median interval between diagnosis and interview was
87 days for cases, all information on risk factors, including that
pertaining to tubal ligations, was truncated at the date of diagnosis
for cases or the date at completion of the telephone screener for
controls. The relationship of breast cancer risk factors to tubal
ligation among the controls was assessed by calculating c2
statistics. The relationship of tubal ligation to breast cancer risk
was assessed through calculation of odds ratios to approximate
relative risks (RRs). Logistic regression analyses were used to
obtain maximum likelihood estimates of RRs and their 95%
confidence intervals (CI) (Breslow and Day, 1980). The signifi-
cance of interactions of variables was determined by using multi-
plicative terms in the regression models, as described by
Thompson (1994).
RESULTS
A total of 25.3% of the cases versus 25.8% of the controls report-
ed a prior tubal ligation. Among the control subjects, tubal ligation
rates were highest in Atlanta (28.1%) and lowest in New Jersey
(21.2%). Previous analyses in this study population have shown
elevations in breast cancer risk associated with White race, a first-
degree family history of breast cancer, a previous breast biopsy,
nulliparity, a late age at first birth, lower body mass, extended use
of oral contraceptives and heavy consumption of alcoholic
beverages (Brinton et al, 1995; Swanson et al, 1996, 1997).
Control subjects were more likely to report a previous tubal liga-
tion if they were black, less educated, young when they bore their
first child, or multiparous. In addition, tubal ligations were more
common among subjects who had been screened by mammog-
raphy, particularly those with multiple mammograms (data not
shown). In contrast, the prevalence of tubal ligations did not
appear to be related to type of menopause, income, body mass
index, years of use of exogenous hormones, or alcohol consump-
tion (data not shown).
Table 2 presents relative risks associated with various aspects of a
previous tubal ligation. The risk for ever having had a tubal ligation,
adjusted only for the frequency matching factors of study site and
age, was 0.95. Further adjustment for race, age at first birth, number
of births and years of education increased this risk to 1.09 (95% CI
0.9–1.3), with the main confounder being late age at first birth.
Adjustment for additional risk factors (including mammographic
screening history) did not further affect the risk. The majority of
subjects had their operations after the age of 30. Although there was
no variation in risk by age at operation for procedure performed
after the age of 25, the unadjusted analysis suggested that operations
prior to this age reduced breast cancer risk. However, these women
also had young ages at first birth and, after adjustment for this as
well as other factors, the reduction in risk was attenuated (RR =
0.94, 95% CI 0.6-1.4). Neither interval since nor calendar year of
operation was predictive of risk. Risk was not altered even among
subjects with recent (< 2 years) or distant (³ 15 years) operations.
Given the slight reduction in risk experienced by women who
had their operations at young ages, we assessed risk in relation to
some combined timing variables, including a cross-classification
of age at and interval since tubal ligation; little variation was
found. The RRs associated with the procedure prior to age 30 were
1.00 (95% CI 0.6–1.6) and 1.20 (0.9–1.6) for those with < 10 and
10+ years since the surgery respectively; with ligation at 30 years
of age or older, comparable risks were 1.06 (0.9–1.3) and 1.07
(0.8–1.4).
Table 1 Per cent of controls reporting a previous tubal ligation by selected
risk factors
Risk factor Number of % Reporting c2
controls previous tubal P-value
Site
Atlanta 919 28.1
New Jersey 462 21.2
Seattle 609 25.9 0.023
Race
White 1555 23.5
Black 323 37.5
Other 112 25.0 0.001
Education
High school or less 586 34.1
Post high school 162 29.0
Some college 509 27.7
College graduate 467 16.5
Post graduate 266 18.4 0.001
Income
< $15 000 161 28.6
$15–24 999 209 24.4
$25–34 999 284 27.8
$35–49 999 388 26.0
$50–69 999 372 26.1
$70–89 999 239 29.3
$90 000+ 284 20.4
Unknown 53 22.6 0.372
Number of births
0 392 3.8
1 362 14.1
2 645 30.2
3 369 41.5
4+ 222 45.0 0.001
Age at first birth
<20 375 37.6
20–24 574 38.3
25–29 406 26.6
30+ 242 12.0
Nulliparous 392 3.8 0.001
Previous mammogram
No 869 23.5
Yes 1120 27.7 0.0881602 LA Brinton et al
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The relationship of tubal ligations showed little variation
according to other breast cancer risk factors (Table 3). A lower risk
was observed for younger subjects (< 35 years of age at breast
cancer diagnosis) (RR = 0.61), while a slightly higher risk was
observed for nulliparous women (RR = 1.49). Both of these risks
were based on relatively small numbers and neither was statisti-
cally different than the null. Risks associated with a tubal ligation
were similar in subjects who reported never versus ever having
had a previous mammogram. Similar risks associated with a tubal
ligation were seen across different menopause categories. Of note
was that there was no differential relationship of tubal ligations
among women who subsequently had a bilateral oophorectomy,
despite this operation leading to a significant reduction in breast
cancer risk in this population (RR = 0.59, 95% CI 0.4–0.8).
Table 2 Relative risks of breast cancer by particulars of a previous tubal ligation
Cases Controls Unadjusted Adjusted
RRa RRb 95% CI
Ever had a tubal ligation
No 1624 1476 1.00 1.00
Yes 549 514 0.95 1.09 0.9–1.3
Age at tubal ligation
< 25 39 51 0.72 0.94 0.6–1.4
25–29 141 127 1.02 1.23 0.9–1.6
30–34 184 179 0.92 1.04 0.8–1.3
35+ 185 157 1.03 1.09 0.9–1.4
Years since tubal ligation
< 5 102 89 1.08 1.23 0.9–1.7
5–9 144 148 0.88 0.97 0.8–1.2
10–14 182 177 0.91 1.07 0.8–1.4
15+ 121 100 1.03 1.29 0.9–1.7
Calendar year of tubal ligation
< 1975 86 64 1.13 1.40 0.9–2.0
1975–1979 149 158 0.83 0.97 0.8–1.2
1980–1984 155 172 0.81 0.91 0.7–1.2
1985+ 159 120 1.23 1.35 1.0–1.8
aAdjusted for study site and age. bAdjusted for study site, age, combination of age at first birth and number of births, and years of education.
Table 3 Relative risks of breast cancer associated with a previous tubal ligation by levels of other risk factors
Cases Controls
Unexposed Exposed Unexposed Exposed RRa 95% CI
Race
Whites 1326 390 1190 365 1.08 0.9–1.3
Non-Whites 298 159 286 149 1.14 0.8–1.6
Site
Atlanta 747 284 661 258 1.13 0.9–1.4
New Jersey 394 115 364 98 1.03 0.7–1.4
Seattle 483 150 451 158 0.98 0.7–1.3
Age
< 35 239 29 255 36 0.61 0.3–1.1
35–39 386 101 370 104 1.06 0.7–1.5
40–44 622 270 500 236 1.06 0.8–1.3
45+ 377 149 351 138 1.17 0.9–1.6
Age at first birth
< 20 183 132 234 141 1.27 0.9–1.8
20–24 351 211 354 220 0.95 0.7–1.2
25–29 343 119 298 108 0.91 0.6–1.2
30+ 281 56 213 29 1.38 0.8–2.3
Nulliparous 465 31 377 15 1.49 0.8–2.8
Menopausal status
Premenopausal 1307 431 1156 389 1.02 0.8–1.2
Menopausal, intact ovaries 120 38 126 51 1.15 0.7–2.0
Menopausal, ovaries removed 186 74 177 68 1.24 0.8–1.9
Previous mammogram
No 628 181 665 204 0.98 0.8–1.3
Yes 996 368 810 310 1.13 0.9–1.4
aRelative risks pertain to the risk associated with tubal ligation within strata of selected risk factors. Risks are adjusted for study site, age, years of education,
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The stage distribution of tumours was 15.4% in situ, 47.2%
stage 1, 35.7% stage 2 or greater, and 1.8% missing. The RRs for
tubal ligation did not vary significantly by stage, being 1.34 (95%
CI 1.0–1.8) for in situ tumours, 1.10 (95% CI 0.9–1.3) for stage 1
cancers and 1.03 (95% CI 0.8–1.3) for stage 2+ disease. Given that
the risk for in situ tumours was elevated, we further assessed this
according to timing but no distinctive pattern was found; in partic-
ular, we did not observe the highest risk for operations performed
recently, which would have supported the notion of a detection
bias.
DISCUSSION
Our finding that tubal ligation is not associated with a reduced risk
of breast cancer is at variance with several other investigations. In
a large record linkage study involving 268 423 women with tubal
ligations, the procedure was associated with a statistically signifi-
cant incidence ratio of 0.84 (Kreiger et al, 1999). Tubal ligations
also appeared to reduce risk (RR = 0.37) in a small case–control
study in Korea (Shin et al, 1996). However, in both studies no
relationship was found with age at or interval since tubal ligation,
arguing against causality. Recently, a 12-year mortality follow-up
study, based on 3086 breast cancer deaths, observed a rate ratio of
0.76 (Calle et al, 1999). Risks were lowest among those sterilized
before age 35 and prior to 1975, suggesting that tissue damage
with early procedures may have been involved.
Similar to this latest study, we initially observed that women
undergoing tubal ligations at young ages (< 25 years) were at
reduced risk, but this relationship did not persist after adjust-
ment for effects of age at first birth. Similar confounding of tubal
ligation effects by reproductive behaviour has been noted in an
endometrial cancer study (Castellsague et al, 1996). One of the
few previous breast cancer studies which was able to adjust for
other risk factors observed tubal ligation to be associated with a
slight increase in risk (RR = 1.2), although no relation was found
with age at or time since surgery (Irwin et al, 1988). This was in
contrast to their findings that bilateral oophorectomy decrea-
sed risk, possibly by curtailing ovarian function at a critical time.
Methodologic differences may be relevant to determine why our
results diverge from the large investigations. Although one of
these studies (Kreiger et al, 1999) was not able to control for
confounding, it is noteworthy that even our unadjusted risks did
not reflect any reduction in risk. In the study by Calle and others
(Calle et al, 1999), breast cancer mortality was the end point rather
than incidence, as in our study. Thus, if patients with tubal
ligations are more intensively screened, as we observed, it is
possible that a spuriously protective effect with mortality would be
apparent. However, we did not observe a reduction in risk even
among subjects with advanced stage disease. Another difference
included our focus on younger women (< 55 years of age).
Although the studies that found a reduced risk associated with
tubal ligation generally focused on women over 50 years of age,
we saw no reduced risk associated with tubal ligation even among
our oldest subjects. In contrast, a reduced risk was found among
the youngest women (< 35 years) in our study.
Unfortunately, neither our study nor any of the previous investi-
gations had information on the type of procedures performed.
These range from techniques performed by laparotomy (mainly
the Pomeroy technique) to those performed by laparoscopy
(unipolar coagulation, bipolar coagulation, Yoon Fallope rings,
Hulka-Clemens clips), which can have different biologic effects,
particularly on blood flow and tissue damage (Donnez et al, 1981).
Differences between investigations may have reflected variations
in the procedures employed, which we could assess only indirectly
and crudely.
Strengths of our study included a large sample size, high rate of
exposure to tubal ligation, and the ability to consider effects of
other breast cancer risk factors. However, given the case-control
design of our study, it is possible that some subjects may have mis-
reported their histories of tubal ligation. Any mis-reporting would
have affected our results primarily if cases and controls were not
equally likely to report their histories (differential misclassifica-
tion) (Armstrong, 1998). It is more likely that our results would
have been influenced by non-differential misclassification, which
can bias results towards the null. Although we were unable to
evaluate the extent to which mis-classification affected results, it
has been found elsewhere that tubal ligations are accurately
reported (Green et al, 1997b).
Although we found no significant effect of tubal ligation on
breast cancer risk, the issue appears to deserve further investiga-
tion, especially given the biologic credibility of a link with breast
cancer risk. This includes clinical reports showing that menstrual
disorders (Neil et al, 1975; Sorenson and Ladehoff, 1979;
DeStefano et al, 1985) and alterations in oestrogen and proges-
terone levels (Cattanach and Milne, 1988; Helm amd Sjoberg,
1983; Hakverdi et al, 1994) have been seen following tubal liga-
tions. Future studies involving prospective designs may be most
useful, given the potential in case–control studies, such as ours, for
difficulties in recall. These studies will need to consider the influ-
ence of other breast cancer risk factors (notably reproductive
behaviour) and to obtain information on the types of tubal liga-
tions performed.
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